AGP Executive Report
Last update: 2 hours agoMedical Innovation in Italy: Aptar Pharma and Aceso Therapeutics announced a collaboration to advance ACT-101, an inhaled antisense therapy candidate for cystic fibrosis, with Nanopharm supporting formulation and device work. Food Safety Alert: The U.S. USDA issued a Class I recall of imported ready-to-eat pork guanciale (about 1,513 pounds) after possible Listeria monocytogenes contamination; no illnesses reported, but consumers and retailers are told not to eat or sell the affected lots. Public Health & Longevity Buzz: A new wave of “immortality” and longevity research is highlighted, from cellular reprogramming and repurposed drugs to wearables estimating “biological age,” as biotech investment in aging reversal keeps accelerating. Health Tech & Care at Home: A review reports that game-based telerehabilitation can help physical therapy for multiple sclerosis patients, pointing to more engaging remote rehab options. Climate/Health Context: Italy’s schools are pushing to delay the start of term amid heatwave conditions, underscoring how rising temperatures are reshaping everyday health decisions.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
